Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 588

1.

Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection.

Fujimura T, Kambayashi Y, Sato Y, Tanita K, Amagai R, Hashimoto A, Hidaka T, Aiba S.

Front Med (Lausanne). 2019 Jun 26;6:140. doi: 10.3389/fmed.2019.00140. eCollection 2019.

PMID:
31297373
Free PMC Article
2.

Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.

Takahashi T, Yamasaki K, Terui H, Omori R, Tsuchiyama K, Fujimura T, Aiba S.

J Dermatol. 2019 Jul 4. doi: 10.1111/1346-8138.14998. [Epub ahead of print]

PMID:
31271451
3.

A novel technique to diagnose non-melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors.

Fujimura T, Okabe T, Tanita K, Sato Y, Chunbing L, Kambayashi Y, Maruyama S, Aiba S.

Exp Dermatol. 2019 Jul 2. doi: 10.1111/exd.13997. [Epub ahead of print]

PMID:
31264287
4.

Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma.

Fujimura T, Sato Y, Tanita K, Lyu C, Kambayashi Y, Amagai R, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Uchi H, Yamamoto Y, Hata H, Funakoshi T, Nonomura Y, Tanaka R, Okuhira H, Wada N, Hashimoto A, Aiba S.

Front Med (Lausanne). 2019 Apr 26;6:86. doi: 10.3389/fmed.2019.00086. eCollection 2019.

5.

Toll-like receptor 2 utilizes RAB11A for melanosome transfer from melanocytes to keratinocytes.

Koike S, Yamasaki K, Yamauchi T, Shimada-Omori R, Tsuchiyama K, Aiba S.

J Dermatol Sci. 2019 May;94(2):310-312. doi: 10.1016/j.jdermsci.2019.04.005. Epub 2019 Apr 30. No abstract available.

PMID:
31079998
6.

Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.

Sato Y, Fujimura T, Mizuashi M, Aiba S.

J Dermatol. 2019 May 7. doi: 10.1111/1346-8138.14906. [Epub ahead of print] No abstract available.

PMID:
31062404
7.

Successful treatment of multiple eruptive adult xanthogranuloma concomitant with xanthelasma palpebrarum with probucol.

Ishihara-Yusa S, Fujimura T, Lyu C, Sugawara M, Sakamoto K, Aiba S.

J Dermatol. 2019 May 3. doi: 10.1111/1346-8138.14903. [Epub ahead of print] No abstract available.

PMID:
31050040
8.

TRIF and MAVS signaling pathways regulate RAB27A induction and melanosome transfer by TLR3 signaling in human epidermal melanocytes.

Koike S, Yamasaki K, Yamauchi T, Shimada-Omori R, Tsuchiyama K, Aiba S.

J Dermatol Sci. 2019 May;94(2):306-309. doi: 10.1016/j.jdermsci.2019.04.004. Epub 2019 Apr 19. No abstract available.

PMID:
31036445
9.

Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's disease.

Sato Y, Fujimura T, Tanita K, Chunbing L, Matsushita S, Fujisawa Y, Otsuka A, Yamamoto Y, Hidaka T, Aiba S.

Exp Dermatol. 2019 Apr 18. doi: 10.1111/exd.13944. [Epub ahead of print]

PMID:
31001887
10.

Three cases of nivolumab therapy-failed advanced melanoma successfully controlled by ipilimumab with intensity-modulated radiotherapy.

Amagai R, Fujimura T, Kambayashi Y, Sato Y, Tanita K, Hashimoto A, Aiba S.

J Dermatol. 2019 May;46(5):449-452. doi: 10.1111/1346-8138.14861. Epub 2019 Mar 25.

PMID:
30908705
11.

FDG-PET detects extensive calcinosis cutis in anti-NXP2 antibody-positive dermatomyositis.

Nakamura N, Izumi R, Hoshi Y, Takai Y, Ono R, Suzuki N, Nagai T, Ishii Y, Ishii T, Harigae H, Okada S, Aiba S, Okiyama N, Fujimoto M, Kuroda H, Tateyama M, Aoki M.

Rheumatology (Oxford). 2019 Mar 16. pii: kez083. doi: 10.1093/rheumatology/kez083. [Epub ahead of print] No abstract available.

PMID:
30879053
12.

First-in-human clinical study of novel technique to diagnose malignant melanoma via thermal conductivity measurements.

Okabe T, Fujimura T, Okajima J, Kambayashi Y, Aiba S, Maruyama S.

Sci Rep. 2019 Mar 7;9(1):3853. doi: 10.1038/s41598-019-40444-6.

13.

Androgens modulate keratinocyte differentiation indirectly through enhancing growth factor production from dermal fibroblasts.

Kumtornrut C, Yamauchi T, Koike S, Aiba S, Yamasaki K.

J Dermatol Sci. 2019 Mar;93(3):150-158. doi: 10.1016/j.jdermsci.2019.01.007. Epub 2019 Jan 26.

PMID:
30792099
14.

Susceptibility Loci for Tanning Ability in the Japanese Population Identified by a Genome-Wide Association Study from the Tohoku Medical Megabank Project Cohort Study.

Shido K, Kojima K, Yamasaki K, Hozawa A, Tamiya G, Ogishima S, Minegishi N, Kawai Y, Tanno K, Suzuki Y, Nagasaki M, Aiba S.

J Invest Dermatol. 2019 Jul;139(7):1605-1608.e13. doi: 10.1016/j.jid.2019.01.015. Epub 2019 Jan 25. No abstract available.

PMID:
30690034
15.

CD30-Positive Angioinvasive Lymphomatoid Papulosis (Type E) Developing from Parapsoriasis en Plaque.

Fujimura T, Lyu C, Tsuchiyama K, Aiba S.

Case Rep Oncol. 2018 Dec 13;11(3):850-854. doi: 10.1159/000495689. eCollection 2018 Sep-Dec.

16.

Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy.

Fujimura T, Kambayashi Y, Sato Y, Tanita K, Tono H, Lyu C, Takahashi T, Hashimoto A, Aiba S.

J Dermatol. 2019 Jul;46(7):e260. doi: 10.1111/1346-8138.14786. Epub 2019 Jan 23. No abstract available.

PMID:
30672615
17.

Anti melanogenic effect of Croton roxburghii and Croton sublyratus leaves in α-MSH stimulated B16F10 cells.

Chatatikun M, Yamauchi T, Yamasaki K, Aiba S, Chiabchalard A.

J Tradit Complement Med. 2018 Apr 30;9(1):66-72. doi: 10.1016/j.jtcme.2017.12.002. eCollection 2019 Jan.

18.

Successful treatment of microcystic adnexal carcinoma on the philtrum with oral S-1 monotherapy.

Haga T, Fujimura T, Aiba S.

J Dermatol. 2019 Jun;46(6):e208-e209. doi: 10.1111/1346-8138.14770. Epub 2019 Jan 21. No abstract available.

PMID:
30663155
19.

Pembrolizumab resolves adult ashy dermatosis developing in patients with squamous cell carcinoma of the lung.

Takeda K, Fujimura T, Tsuchiyama K, Lyu C, Aiba S.

J Dermatol. 2019 Mar;46(3):271-273. doi: 10.1111/1346-8138.14775. Epub 2019 Jan 21.

PMID:
30663147
20.

Severe rhabdomyolysis developing in an advanced melanoma patient treated by pembrolizumab followed by dabrafenib trametinib combined therapy.

Irimada M, Fujimura T, Kambayashi Y, Tsukada A, Takahashi T, Hashimoto A, Aiba S.

J Dermatol. 2019 Jul;46(7):e256-e258. doi: 10.1111/1346-8138.14778. Epub 2019 Jan 18. No abstract available.

PMID:
30656733
21.

Absolute asymmetric Strecker synthesis in a mixed aqueous medium: reliable access to enantioenriched α-aminonitrile.

Miyagawa S, Aiba S, Kawamoto H, Tokunaga Y, Kawasaki T.

Org Biomol Chem. 2019 Jan 31;17(5):1238-1244. doi: 10.1039/c8ob03092h.

PMID:
30656321
22.

BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trials.

Fujimura T, Hidaka T, Kambayashi Y, Aiba S.

Expert Opin Investig Drugs. 2019 Feb;28(2):143-148. doi: 10.1080/13543784.2019.1558442. Epub 2018 Dec 16. Review.

PMID:
30556435
23.

The performance of an in vitro skin sensitisation test, IL-8 Luc assay (OECD442E), and the integrated approach with direct peptide reactive assay (DPRA).

Kimura Y, Watanabe M, Suzuki N, Iwaki T, Yamakage K, Saito K, Nakajima Y, Fujimura C, Ohmiya Y, Omori T, Kojima H, Aiba S.

J Toxicol Sci. 2018;43(12):741-749. doi: 10.2131/jts.43.741.

24.

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma.

Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Wada N, Irie H, Hidaka T, Hashimoto A, Aiba S.

Front Oncol. 2018 Nov 19;8:530. doi: 10.3389/fonc.2018.00530. eCollection 2018.

25.

Artificial Pigmented Human Skin Created by Muse Cells.

Yamauchi T, Yamasaki K, Tsuchiyama K, Aiba S.

Adv Exp Med Biol. 2018;1103:255-271. doi: 10.1007/978-4-431-56847-6_14.

PMID:
30484234
26.

Keratoacanthoma Centrifugum Marginatum with Spontaneous Regression and Its Possible Differential Diagnosis.

Amagai R, Fujimura T, Kambayashi Y, Furudate S, Sato Y, Tanita K, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Oct 24;11(3):671-675. doi: 10.1159/000493089. eCollection 2018 Sep-Dec.

27.

Breast Cancer Metastasis in the Skin with Hyperkeratotic Pigmentation Caused by Melanocyte Colonization.

Ishihara-Yusa S, Fujimura T, Lyu C, Sugawara M, Sakamoto K, Aiba S.

Case Rep Oncol. 2018 Oct 23;11(3):660-664. doi: 10.1159/000493186. eCollection 2018 Sep-Dec.

28.

Eruptive xanthomas in a patient with soft-drink diabetic ketosis and apolipoprotein E4/2.

Tsuchiya S, Sawada S, Takeda K, Takahashi K, Nakajima T, Kohata M, Kurosawa S, Satake C, Imai J, Kikuchi K, Aiba S, Katagiri H.

Endocr J. 2019 Jan 28;66(1):107-114. doi: 10.1507/endocrj.EJ18-0356. Epub 2018 Nov 2.

29.

Eruptive keratoacanthoma with spontaneous regression arising from a cervical squamous cell carcinoma patient treated with nivolumab.

Fujimura T, Lyu C, Tsukada A, Sato Y, Kambayashi Y, Aiba S.

J Dermatol. 2019 May;46(5):e177-e178. doi: 10.1111/1346-8138.14684. Epub 2018 Oct 24. No abstract available.

PMID:
30353913
30.

A Case of Primary Cutaneous Basal Cell Carcinosarcoma.

Suzuki H, Hashimoto A, Saito R, Izumi M, Aiba S.

Case Rep Dermatol. 2018 Aug 28;10(2):208-215. doi: 10.1159/000492525. eCollection 2018 May-Aug.

31.

Minocycline decreases Th2 chemokines from M2 macrophages: Possible mechanisms for the suppression of bullous pemphigoid by traditional bullous disease drugs.

Tanita K, Fujimura T, Sato Y, Lyu C, Aiba S.

Exp Dermatol. 2018 Nov;27(11):1268-1272. doi: 10.1111/exd.13779. Epub 2018 Oct 9.

PMID:
30192415
32.

Edible oil methods to remove asphalt on burns.

Yamazaki E, Shido K, Yamasaki K, Aiba S.

J Dermatol. 2018 Nov;45(11):1331-1336. doi: 10.1111/1346-8138.14590. Epub 2018 Aug 6. Review.

PMID:
30079570
33.

Pigmented Epithelioid Melanocytoma (Animal Types of Melanoma) on the Nose.

Ohuchi K, Fujimura T, Kambayashi Y, Tono H, Ohtake E, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Jun 13;11(2):378-382. doi: 10.1159/000490237. eCollection 2018 May-Aug.

34.

Widely Spread Unilateral Inflammatory Linear Verrucous Epidermal Nevus (ILVEN).

Tanita K, Fujimura T, Sato Y, Lyu C, Aiba S.

Case Rep Dermatol. 2018 Jun 14;10(2):170-175. doi: 10.1159/000489876. eCollection 2018 May-Aug.

35.

PD-L1-Expressing Radiation-Associated Angiosarcoma after Primary Breast Cancer.

Takeda K, Fujimura T, Lyu C, Tsukada A, Tsuchiyama K, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 May 29;11(2):330-335. doi: 10.1159/000489628. eCollection 2018 May-Aug.

36.

Two cases of dabrafenib and trametinib therapy-failed advanced melanoma successfully controlled by nivolumab monotherapy.

Sato Y, Fujimura T, Kambayashi Y, Tanita K, Tono H, Hashimoto A, Aiba S.

J Dermatol. 2018 Sep;45(9):1105-1108. doi: 10.1111/1346-8138.14508. Epub 2018 Jun 20.

PMID:
29923635
37.

Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy.

Sato Y, Fujimura T, Kambayashi Y, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Mar 28;11(1):212-215. doi: 10.1159/000488236. eCollection 2018 Jan-Apr.

38.

Three patients with advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and chemokine (C-X-C motif) ligand 10 as possible biomarkers predicting the biological behaviour of angiosarcoma.

Fujimura T, Sato Y, Kambayashi Y, Tanita K, Tsukada A, Terui H, Hashimoto A, Aiba S.

Br J Dermatol. 2018 Dec;179(6):1392-1395. doi: 10.1111/bjd.16676. Epub 2018 Jul 5.

PMID:
29663331
39.

Expression dynamics of self-renewal factors for spermatogonial stem cells in the mouse testis.

Sakai M, Masaki K, Aiba S, Tone M, Takashima S.

J Reprod Dev. 2018 Jun 22;64(3):267-275. doi: 10.1262/jrd.2018-015. Epub 2018 Apr 16.

40.

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.

Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Furudate S, Hidaka T, Aiba S.

Oncotarget. 2018 Feb 15;9(21):15542-15551. doi: 10.18632/oncotarget.24509. eCollection 2018 Mar 20.

41.

Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab.

Tanita K, Fujimura T, Kambayashi Y, Tsukada A, Sato Y, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Feb 15;11(1):114-118. doi: 10.1159/000487127. eCollection 2018 Jan-Apr.

42.

Toll-like receptors 2 and 3 enhance melanogenesis and melanosome transport in human melanocytes.

Koike S, Yamasaki K, Yamauchi T, Inoue M, Shimada-Ohmori R, Tsuchiyama K, Aiba S.

Pigment Cell Melanoma Res. 2018 Sep;31(5):570-584. doi: 10.1111/pcmr.12703. Epub 2018 Apr 16.

PMID:
29603875
43.

Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay.

Kimura Y, Fujimura C, Ito Y, Takahashi T, Terui H, Aiba S.

Arch Toxicol. 2018 Jun;92(6):2043-2054. doi: 10.1007/s00204-018-2199-7. Epub 2018 Mar 29.

PMID:
29594315
44.

Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy.

Fujimura T, Tanita K, Sato Y, Kambayashi Y, Furudate S, Tsukada A, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Jan 16;11(1):29-32. doi: 10.1159/000486278. eCollection 2018 Jan-Apr.

45.

Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical Imiquimod.

Fujimura T, Kambayashi Y, Sato Y, Tanita K, Furudate S, Tsukada A, Tono H, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Jan 4;11(1):1-5. doi: 10.1159/000485612. eCollection 2018 Jan-Apr.

46.

HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.

Fujimura T, Kambayashi Y, Tanita K, Sato Y, Hidaka T, Otsuka A, Tanaka H, Furudate S, Hashimoto A, Aiba S.

J Dermatol. 2018 Jun;45(6):735-737. doi: 10.1111/1346-8138.14273. Epub 2018 Feb 27.

PMID:
29488243
47.

Phylogenetic classification of the world's tropical forests.

Slik JWF, Franklin J, Arroyo-Rodríguez V, Field R, Aguilar S, Aguirre N, Ahumada J, Aiba SI, Alves LF, K A, Avella A, Mora F, Aymard C GA, Báez S, Balvanera P, Bastian ML, Bastin JF, Bellingham PJ, van den Berg E, da Conceição Bispo P, Boeckx P, Boehning-Gaese K, Bongers F, Boyle B, Brambach F, Brearley FQ, Brown S, Chai SL, Chazdon RL, Chen S, Chhang P, Chuyong G, Ewango C, Coronado IM, Cristóbal-Azkarate J, Culmsee H, Damas K, Dattaraja HS, Davidar P, DeWalt SJ, Din H, Drake DR, Duque A, Durigan G, Eichhorn K, Eler ES, Enoki T, Ensslin A, Fandohan AB, Farwig N, Feeley KJ, Fischer M, Forshed O, Garcia QS, Garkoti SC, Gillespie TW, Gillet JF, Gonmadje C, Granzow-de la Cerda I, Griffith DM, Grogan J, Hakeem KR, Harris DJ, Harrison RD, Hector A, Hemp A, Homeier J, Hussain MS, Ibarra-Manríquez G, Hanum IF, Imai N, Jansen PA, Joly CA, Joseph S, Kartawinata K, Kearsley E, Kelly DL, Kessler M, Killeen TJ, Kooyman RM, Laumonier Y, Laurance SG, Laurance WF, Lawes MJ, Letcher SG, Lindsell J, Lovett J, Lozada J, Lu X, Lykke AM, Mahmud KB, Mahayani NPD, Mansor A, Marshall AR, Martin EH, Calderado Leal Matos D, Meave JA, Melo FPL, Mendoza ZHA, Metali F, Medjibe VP, Metzger JP, Metzker T, Mohandass D, Munguía-Rosas MA, Muñoz R, Nurtjahy E, de Oliveira EL, Onrizal, Parolin P, Parren M, Parthasarathy N, Paudel E, Perez R, Pérez-García EA, Pommer U, Poorter L, Qie L, Piedade MTF, Pinto JRR, Poulsen AD, Poulsen JR, Powers JS, Prasad RC, Puyravaud JP, Rangel O, Reitsma J, Rocha DSB, Rolim S, Rovero F, Rozak A, Ruokolainen K, Rutishauser E, Rutten G, Mohd Said MN, Saiter FZ, Saner P, Santos B, Dos Santos JR, Sarker SK, Schmitt CB, Schoengart J, Schulze M, Sheil D, Sist P, Souza AF, Spironello WR, Sposito T, Steinmetz R, Stevart T, Suganuma MS, Sukri R, Sultana A, Sukumar R, Sunderland T, Supriyadi, Suresh HS, Suzuki E, Tabarelli M, Tang J, Tanner EVJ, Targhetta N, Theilade I, Thomas D, Timberlake J, de Morisson Valeriano M, van Valkenburg J, Van Do T, Van Sam H, Vandermeer JH, Verbeeck H, Vetaas OR, Adekunle V, Vieira SA, Webb CO, Webb EL, Whitfeld T, Wich S, Williams J, Wiser S, Wittmann F, Yang X, Adou Yao CY, Yap SL, Zahawi RA, Zakaria R, Zang R.

Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1837-1842. doi: 10.1073/pnas.1714977115. Epub 2018 Feb 5. Erratum in: Proc Natl Acad Sci U S A. 2018 Mar 12;:.

48.

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Fujimura T, Kambayashi Y, Fujisawa Y, Hidaka T, Aiba S.

Front Oncol. 2018 Jan 23;8:3. doi: 10.3389/fonc.2018.00003. eCollection 2018. Review.

49.

Efficacy of oral cholecalciferol on rhododendrol-induced vitiligo: A blinded randomized clinical trial.

Watabe A, Yamasaki K, Asano M, Kanbayashi Y, Nasu-Tamabuchi M, Terui H, Furudate S, Kakizaki A, Tsuchiyama K, Kimura Y, Ito Y, Kikuchi K, Aiba S.

J Dermatol. 2018 Apr;45(4):456-462. doi: 10.1111/1346-8138.14244. Epub 2018 Feb 5.

PMID:
29399865
50.

Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable.

Ozawa M, Sasahara Y, Aiba S.

J Dermatol. 2018 May;45(5):606-608. doi: 10.1111/1346-8138.14243. Epub 2018 Feb 5.

PMID:
29399856

Supplemental Content

Support Center